Wednesday 24 June

Essentially Biological Processes After G 3/19

When and where

Date and time

Start: Wednesday 24 June 2020, 02:00 PM

End: Wednesday 24 June 2020, 03:00 PM

Event Overview

Now that the Enlarged Board of Appeal in G 3/19 has confirmed that products obtained by an essentially biological process are not patentable, Rhiannon Turner will provide an overview of the decision and how we got here. She will also consider the remaining options for IP protection for such products.


Fellows, Students


Dr Rhiannon Turner, Greaves Brewster

Dr Rhiannon Turner, Greaves Brewster

Dr Rhiannon Turner has been in the profession since 2002 and heads Greaves Brewster’s Life Sciences team. She has a degree in Natural Sciences and a PhD, both from Cambridge University.

Rhiannon has professional experience in a diverse range of technical areas, including genome engineering, many different types of diagnostic assays, PCR technology, vaccines and antibodies, natural product biotechnology, synthetic biology, biofuels, foodstuffs, assay consumables, orthopaedic implants, and at-sea rescue devices. One of the things she enjoys about her role is the opportunity work at the forefront of scientific knowledge.

Over the last few years, Rhiannon has been leading the Greaves Brewster team, in close collaboration with colleagues, in support of a large client working in the field of CRISPR gene editing.

Rhiannon was recognised by Managing IP as one of their IPStars again in 2020.

The event has been added to your basket:

Essentially Biological Processes After G 3/19

Proceed to basket

Shopping Basket

No products in the cart.

Are you a CIPA member?

Sign in to your account to register for the event

Forgotten password?

If you are not yet registered or a member of CIPA, please register here

Skip to content